0001209191-21-036101.txt : 20210526 0001209191-21-036101.hdr.sgml : 20210526 20210526202556 ACCESSION NUMBER: 0001209191-21-036101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210319 FILED AS OF DATE: 20210526 DATE AS OF CHANGE: 20210526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hindson Benjamin J. CENTRAL INDEX KEY: 0001786391 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39035 FILM NUMBER: 21968121 MAIL ADDRESS: STREET 1: 10X GENOMICS, INC. STREET 2: 6230 STONERIDGE MALL ROAD CITY: PLEASANTON STATE: CA ZIP: 94588 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 10x Genomics, Inc. CENTRAL INDEX KEY: 0001770787 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 455614458 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6230 STONERIDGE MALL ROAD CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: (925) 401-7300 MAIL ADDRESS: STREET 1: 6230 STONERIDGE MALL ROAD CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: 10X Genomics, Inc. DATE OF NAME CHANGE: 20190315 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-19 0 0001770787 10x Genomics, Inc. TXG 0001786391 Hindson Benjamin J. C/O 10X GENOMICS, INC. 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588 1 1 0 0 See Remarks Class A Common Stock 2021-03-19 4 A 0 11169 0.00 A 47805 D Class A Common Stock 2021-05-24 4 S 0 351 162.6596 D 47454 D Stock Option (right to buy) 177.76 2021-03-19 4 A 0 27922 0.00 A 2031-03-19 Class A Common Stock 27922 27922 D These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-sixteenth of the RSUs shall vest on May 21, 2021 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. The number of shares beneficially owned following the reported transaction is as of March 19, 2021. These shares were sold to cover tax withholding obligations in connection with the vesting of RSUs. The number of shares beneficially owned following the reported transaction is as of May 24, 2021. This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one forty-eighth of the shares on May 1, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Chief Scientific Officer and President /s/ Eric S. Whitaker, as Attorney-in-Fact 2002-05-26